Silexion Therapeutics LTD (SLXN)

1.07

-0.04 (-3.60%)

At close: Feb 28, 2025, 3:59 PM

1.09

1.40%

After-hours: Feb 28, 2025, 05:29 PM EST

Silexion Therapeutics LTD Cash Flow Statement

Table Mode

Year	FY23	FY22
Net Income	-5.11M	-3.49M
Depreciation & Amortization	45K	57K
Stock-Based Compensation	130K	125K
Other Working Capital	-10K	317K
Other Non-Cash Items	317K	-268K
Deferred Income Tax	n/a	n/a
Change in Working Capital	87K	239K
Operating Cash Flow	-4.53M	-3.33M
Capital Expenditures	-12K	-40K
Acquisitions	n/a	n/a
Purchase of Investments	n/a	-500K
Sales Maturities Of Investments	507K	16K
Other Investing Acitivies	78K	n/a
Investing Cash Flow	573K	-524K
Debt Repayment	n/a	n/a
Common Stock Repurchased	n/a	n/a
Dividend Paid	n/a	n/a
Other Financial Acitivies	522K	2.75M
Financial Cash Flow	522K	2.75M
Net Cash Flow	-3.66M	-1.77M
Free Cash Flow	-4.54M	-3.38M